|Day Low/High||403.00 / 413.04|
|52 Wk Low/High||208.25 / 474.70|
Here's to the removal of uncertainty -- and thousands of campaign signs on thousands of lawns in my neighborhood.
Neither candidate seems to be the enemy of the market -- at least not yet.
It is going to take successful vaccines and therapies and much lower unemployment to revive most of Walt Disney Co.'s businesses.
There was a mild increase in trading volume at the New York Stock Exchange, but it was a rotational shift.
These names should do well as long as the coronavirus is a threat, and still continue to grow once it is past.
After a strong day for fixed-income markets, let's learn from 2008 how to play this volatility.
You can sell any stock that's up and take that money to the bank and no one will say, "sorry that was made off of euphoria, we can't take it."
Tuesday's sharp gains put the bull back in the picture.
The timing of this morning's rally? Almost simultaneously news broke from both China and the UK of possible drugs to fight coronavirus.
The big tech names are once again surging, and as long as they keep their noses clean, that should continue.
Watch for analysts and strategists to turn into armageddonists forgetting that China's the real issue.
OPEC forecasts declining demand for OPEC oil, not a decline in global demand. That distinction is key.
Disney, Qualcomm and Square are among 75 key reports we are watching.
The nation enters an electoral season. The drug companies for the most part, have no friends on either side of the aisle.
On the biggest day for earnings reports in the S&P let me give you my scorecard to date so you know which pile your stocks might land in.
Understand that the expected Fed rate cut today is not about recent economic performance in the least.
I will very much approach the environment provided (China talks) from the view of the pragmatic. I will trade whatever is in front of me.
The fear will subside around health care stocks, and here is why.
I've spotlighted three blue-chip companies with stock prices that are at ridiculously low valuations right now.
The free press that the progressive push for Medicare got on Tuesday morning is hurting the healthcare sector.
The health benefit giant's fundamentals are good, but there are more symptoms to consider for a proper examination.
Has the sun set on what was the greatest wealth creator of any company when the stock traded north of a trillion dollars? No.